Abstract
Malignant pleural mesothelioma (MPM) is a highly aggressive tumor with poor prognosis and closely related to exposure to asbestos. MPM is a heterogeneous tumor with three main histological subtypes, epithelioid, sarcomatoid, and biphasic types, among which sarcomatoid type shows the poorest prognosis. The Ror-family of receptor tyrosine kinases, Ror1 and Ror2, is expressed in various types of tumor cells at higher levels and affects their aggressiveness. However, it is currently unknown whether they are expressed in and involved in aggressiveness of MPM. Here, we show that Ror1 and Ror2 are expressed in clinical specimens and cell lines of MPM with different histological features. Studies using MPM cell lines indicate that expression of Ror2 is associated tightly with high invasiveness of MPM cells, whereas Ror1 can contribute to their invasion in the absence of Ror2. However, both Ror1 and Ror2 promote proliferation of MPM cells. We also show that promoted invasion and proliferation of MPM cells by Ror signaling can be mediated by the Rho-family of small GTPases, Rac1, and Cdc42. These findings elucidate the critical role of Ror signaling in promoting invasion and proliferation of MPM cells.
References
Jun 13, 2001·Oncogene·E Shaulian, M Karin
Jan 11, 2002·Molecular and Cellular Biology·Michiru NishitaKensaku Mizuno
Jul 4, 2003·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Isao OishiYasuhiro Minami
Oct 14, 2005·The New England Journal of Medicine·Bruce W S Robinson, Richard A Lake
Dec 6, 2005·Hematology/oncology Clinics of North America·Raphael Bueno
May 11, 2006·Japanese Journal of Clinical Oncology·Naoko KanazawaAkira Oshima
Nov 15, 2006·The Journal of Cell Biology·Michiru NishitaYasuhiro Minami
Dec 15, 2006·Journal of Cellular Physiology·Chunhong Yan, Douglas D Boyd
Mar 28, 2008·PloS One·Shiva AkbarzadehJohn K Heath
Jun 30, 2009·Oncogene·M EnomotoY Minami
Oct 6, 2009·Oncogene·M P O'ConnellA T Weeraratna
Nov 17, 2009·The EMBO Journal·Akira SatoAkira Kikuchi
Jan 7, 2010·British Journal of Cancer·J E NuttJ Lunec
Apr 3, 2010·Trends in Cell Biology·Michiru NishitaYasuhiro Minami
Aug 28, 2010·Japanese Journal of Clinical Oncology·Shuko NojiriTakumi Kishimoto
Mar 18, 2011·Journal of Cellular Physiology·Michele CarboneHaining Yang
Feb 14, 2012·Journal of Cell Science·Mitsuharu EndoYasuhiro Minami
Jun 5, 2012·Clinical Lung Cancer·Steven C KaoStephen Clarke
Sep 25, 2012·Nature Medicine·Dahu ChenLi Ma
Jun 13, 2013·Genes to Cells : Devoted to Molecular & Cellular Mechanisms·Xin LiYasuhiro Minami
Jun 4, 2014·Molecular and Cellular Biology·Michiru NishitaYasuhiro Minami
Dec 3, 2014·Annals of Global Health·Arthur L Frank, T K Joshi
Jan 17, 2015·Nature Reviews. Cancer·Toshiro MoroishiKun-Liang Guan
Jan 27, 2015·International Review of Cell and Molecular Biology·Mitsuharu EndoYasuhiro Minami
Apr 23, 2015·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Akihiko MiyanagaTesshi Yamada
Oct 12, 2016·Glia·Mitsuharu EndoYasuhiro Minami
Jan 28, 2017·Scientific Reports·Michiru NishitaYasuhiro Minami
May 5, 2017·Journal of Cellular and Molecular Medicine·Wen-Qian ZhangLiang You
Aug 10, 2017·The Journal of Biological Chemistry·Koki KamizakiYasuhiro Minami
Oct 27, 2017·Cell Structure and Function·Daiki TakahashiMichiru Nishita
Citations
Dec 28, 2019·Journal of Translational Medicine·Rui LiPeishu Liu
Jan 16, 2021·Cells·Kerstin MenckAnnalen Bleckmann
Dec 7, 2019·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Noriko MiyakeNagio Takigawa
Jun 23, 2021·Journal of the American Heart Association·Nicholas W ChavkinKenneth Walsh
Jan 16, 2022·Critical Reviews in Oncology/hematology·María Victoria Castro, Pablo Lopez-Bergami